SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030100
Filing Date
2019-08-07
Accepted
2019-08-07 16:22:02
Documents
77
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20190630.htm   iXBRL 10-Q 3285562
2 EX-10.1 rgnx-ex101_82.htm EX-10.1 14040
3 EX-31.1 rgnx-ex311_64.htm EX-31.1 16912
4 EX-31.2 rgnx-ex312_63.htm EX-31.2 16853
5 EX-32.1 rgnx-ex321_62.htm EX-32.1 11295
  Complete submission text file 0001564590-19-030100.txt   12562586

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20190630.xsd EX-101.SCH 62246
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20190630_cal.xml EX-101.CAL 66621
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20190630_def.xml EX-101.DEF 251243
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20190630_lab.xml EX-101.LAB 513755
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20190630_pre.xml EX-101.PRE 410594
11 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-10q_20190630_htm.xml XML 3014185
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 191005809
SIC: 2836 Biological Products, (No Diagnostic Substances)